Patents by Inventor Daniel R. Hyduke

Daniel R. Hyduke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-DLL3 DRUG CONJUGATES FOR TREATING TUMORS AT RISK OF NEUROENDOCRINE TRANSITION
    Publication number: 20190201542
    Abstract: Methods of treating tumors at risk for neuroendocrine transition using anti-delta-like ligand 3 (DLL3) antibody drug conjugates (ADCs) are provided.
    Type: Application
    Filed: May 19, 2017
    Publication date: July 4, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Laura SAUNDERS, Robert A. STULL, Daniel R. HYDUKE, Enying YOU
  • Method for in silico Modeling of Gene Product Expression and Metabolism
    Publication number: 20150127317
    Abstract: The present invention provides an integrated model of metabolic and macromolecular expression (ME-Model), and a method for reconstructing an ME-Model from biological data. Specifically, the present invention provides a ME-Model which uses a biochemical knowledgebase of an organism to accurately determine the metabolic and macromolecular phenotype of the organism under different conditions. Further, the present invention provides a method to determine the most efficient conditions for producing a product from an organism.
    Type: Application
    Filed: May 9, 2013
    Publication date: May 7, 2015
    Inventors: Daniel R. Hyduke, Joshua A. Lerman, Bernhard O. Palsson, Edward O'Brien